首页> 外文期刊>BMC Cancer >Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results
【24h】

Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results

机译:亚科学对结直肠癌筛查方案的影响在中国结肠直肠癌筛查计划中的影响:基于自然社区筛查结果的分析

获取原文
           

摘要

To date, no single colorectal cancer (CRC) screening strategy has been determined to be applicable worldwide. In China, a CRC screening protocol that combines double fecal immunochemical tests (FITs) and a high-risk factor questionnaire (HRFQ) as the first stage of screening and colonoscopy as the second stage of screening (scenario A) was adapted by the Chinese Ministry of Health in 2006. However, applying this CRC screening protocol nationally remains difficult because its effectiveness and convenience are controversial. This study evaluated the effects of subitems of the CRC screening protocol in China. CRC screening results (scenario A) from Jiashan County, China, (2007-2009) were used to analyze the detection rates of CRC and advanced neoplasms as well as the cost-effectiveness of the protocol. Scenario A was divided into scenarios B-G (by selecting some items at the first stage of screening) for analysis. Compared with scenario A, removing the whole HRFQ (scenario F) reduced advanced neoplasm and adenoma detections by 29.8 and 41.2%, respectively, whereas the whole HRFQ accounted for 10.1% of the total screening cost. Removing FITs (scenario G) reduced CRC, advanced neoplasm and adenoma detections by 71.8, 56.9 and 47.7%, respectively, and the costs per case of CRC and advanced neoplasm were 82.0 and 19.1% higher, respectively, than those in scenario A. In scenarios B-E (deleting some high-risk factor questions on the HRFQ), the odds ratios (ORs) of the detection rates and costs per CRC, advanced neoplasm, adenoma, and neoplasm case were near 1.00. Scenarios C and D reduced the high-risk population and total screening costs by less than 6.0 and 4.1%, respectively. Scenarios E and B (FITs and a personal history of cancer or colorectal adenoma were reserved) reduced the high-risk population by 17.6 and 24.2% and the total screening costs by 11.2 and 15.4%, respectively, while the numbers of CRC cases were not missed, and advanced neoplasms detected decreased by only 5 and 11%, respectively. The results of this study demonstrate that FITs and a personal history of colorectal adenoma are the most effective items in the Chinese CRC screening protocol.
机译:迄今为止,没有确定全球适用的单一结肠直肠癌(CRC)筛选策略。在中国,将双重粪便免疫化学测试(适合)和高危因素问卷(HRFQ)结合为筛选和结肠镜检查的第一阶段,作为筛选的第一阶段(情景A)的第一个阶段(情景A)组成的CRC筛选方案。然而,2006年健康。但是,在国家筛选议定书中申请全国仍然困难,因为其有效性和便利性是有争议的。本研究评估了CRC筛选协议子项在中国的影响。 CRC筛选结果(CRC筛选结果(嘉年县)(2007-2009)用于分析CRC和先进肿瘤的检测率,以及协议的成本效益。场景A分为方案B-G(通过在筛选第一阶段选择某些项目)进行分析。与场景A相比,除去整个HRFQ(场景F)分别将先进的肿瘤和腺瘤检测减少29.8%和41.2%,而整个HRFQ占总筛选成本的10.1%。除去拟合(情景G)减少了CRC,晚期肿瘤和腺瘤检测分别为71.8,56.9和47.7%,并且每种情况下的费用和晚期肿瘤的成本分别比方案A中的人数分别为82.0%和19.1%。场景(删除HRFQ的一些高风险因素问题),检测率的差距(或)每CRC检测率和成本,晚期肿瘤,腺瘤和肿瘤盒接近1.00。情景C和D分别将高风险人口和总筛选成本降低了小于6.0%和4.1%。情景E和B(患有癌症或结肠直肠腺瘤的个人历史保留)将高危人群减少17.6%和24.2%,分别将总筛选成本分别为11.2和15.4%,而CRC案件的数量则不是未缺少,检测到的晚期肿瘤分别下降了5%和11%。本研究的结果表明,结肠直肠腺瘤的拟合和个人历史是中国CRC筛选方案中最有效的项目。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号